DarioHealth Corp Cash Flow Conversion Efficiency
DarioHealth Corp cash flow conversion efficiency. Based on the latest financial reports, DarioHealth Corp (DRIO) has a cash flow conversion efficiency ratio of -0.100x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.49 Million) by net assets ($55.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of DarioHealth Corp (2012–2025)
Cash flow conversion efficiency of DarioHealth Corp from 2012 to 2025. This chart illustrates how DarioHealth Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View DarioHealth Corp share price for real-time trading data and today's change.
DarioHealth Corp Cash Flow Conversion Ratio Explained
DarioHealth Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
DarioHealth Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DarioHealth Corp ranked by their cash flow conversion efficiency. Also see DarioHealth Corp (DRIO) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Axita Cotton Limited
NSE:AXITA
|
-0.008x |
|
Numulae Gestion de Servicios SOCIMI SA
MC:YNUM
|
-0.001x |
|
Harte Hanks Inc
NASDAQ:HHS
|
-0.135x |
|
Allakos Inc
NASDAQ:ALLK
|
-0.511x |
|
Eskay Mining Corp
V:ESK
|
-0.087x |
|
Sypris Solutions Inc
NASDAQ:SYPR
|
-0.169x |
|
Sentien Printing Factory Co Ltd
TWO:8410
|
0.045x |
|
rYojbaba Co., Ltd. Common Shares
NASDAQ:RYOJ
|
0.000x |
Annual Cash Flow Conversion Efficiency for DarioHealth Corp (2012–2025)
The table below shows the annual cash flow conversion efficiency of DarioHealth Corp from 2012 to 2025. Review DarioHealth Corp free cash flow to debt ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $67.92 Million | $-25.94 Million | -0.382x | +28.67% |
| 2024-12-31 | $72.02 Million | $-38.56 Million | -0.535x | -2.48% |
| 2023-12-31 | $58.14 Million | $-30.38 Million | -0.522x | +12.64% |
| 2022-12-31 | $80.00 Million | $-47.84 Million | -0.598x | -1.50% |
| 2021-12-31 | $85.55 Million | $-50.41 Million | -0.589x | +6.47% |
| 2020-12-31 | $28.15 Million | $-17.74 Million | -0.630x | +24.30% |
| 2019-12-31 | $18.89 Million | $-15.72 Million | -0.832x | +35.24% |
| 2018-12-31 | $8.93 Million | $-11.47 Million | -1.285x | +52.30% |
| 2017-12-31 | $3.94 Million | $-10.62 Million | -2.694x | -310.34% |
| 2016-12-31 | $-6.54 Million | $-8.38 Million | 1.281x | +115.86% |
| 2015-12-31 | $777.00K | $-6.28 Million | -8.079x | -338.94% |
| 2014-12-31 | $-2.54 Million | $-8.58 Million | 3.381x | -96.16% |
| 2013-12-31 | $-86.38K | $-7.60 Million | 87.979x | +3053.32% |
| 2012-12-31 | $-1.07 Million | $-2.98 Million | 2.790x | -- |
About DarioHealth Corp
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to crea… Read more